Royalty Pharma plc (RPRX) Reports Q4 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $53.57 +1.15%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
JFIN, KEQU, LASE, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
- Netflix (NFLX) call put ratio 2.3 calls to 1 put
- Increasing unusual call option volume: GDS AM PGEN DFTX CTSH SWKS AIG BFLY OTLK EH CABA
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
